Ultimovacs
Menu Close ✕
  • About
    • About Ultimovacs
    • Team
    • Board of directors
  • Technology
    • Technology overview
    • Immunotherapy
  • Clinical Studies
    • Phase II trials
    • Phase I trials
    • Partnering
    • Expanded access
  • Investors
    • Shares
    • Financial reports
    • Presentations and publications
    • Investor relations contacts
    • Analyst coverage
    • Governance
    • ESG
    • News
  • Contact
Ultimovacs  –  News  –  Ultimovacs Presentation at TD Cowen Healthcare Conference

Ultimovacs Presentation at TD Cowen Healthcare Conference

CEO Carlos de Sousa and CMO Jens Bjørheim are presenting Ultimovacs at TD Cowen 43rd Annual Health Care Conference, March 5 – 8, in Boston, MA.

Link to the event:
https://wsw.com/webcast/cowen132/ulti.ol/2447550

Print this article
6, March, 2023
E-mail: mail@ultimovacs.com
E-mail: ir@ultimovacs.com
Phone number: +47 413 80 080
Ullernchausséen 64
0379 Oslo
Norway
View in Google Maps

Technology

  • Technology
  • Clinical studies
  • Immunotherapy

Ultimovacs

  • About Ultimovacs
  • Team
  • Board of directors
  • Contact us

Investors

  • Share information
  • Financial reports
  • Investor relations contacts
  • News
Copyright © Ultimovacs ASA 2023